Dec. 22, 2010 -- The FDA says it is working with Abbott Diabetes Care to recall 359 million defective glucose test strips -- sold under a variety of brand names -- that may make bloodglucose levels look lower than they really are.
The FDA says the defective strips “can lead users to try to raise their blood glucose when it is unnecessary or to fail to treat elevated blood glucose due to a falsely low reading,” and that “both scenarios pose health risks.”
Abbott says the defective strips aren’t absorbing enough blood to provide an accurate reading. The company also says test strips stored for a long time in medicine cabinets or test strips that have been exposed to warm temperatures could give false results.
“FDA and Abbott are reviewing the cause of the manufacturing defect to avoid this problem in the future,” Alberto Gutierrez, PhD, of FDA’s Center for Devices and Radiological Health, says in a news release.
Gutierrez says diabetes patients “should be aware of the recalled glucose test strips and take steps to prevent them from affecting their health.”
The strips being recalled are used with Abbott’s MediSense Optium, Precision Xceed Pro, Precision Xtra, Optium, Optium EZ, and ReliOn Ultima blood glucose monitoring systems.
The lots were manufactured between January and May of this year and sold in retail stores in the U.S. and Puerto Rico. The strips are used both by consumers and health care professionals.
Abbott says the strips should not be used and will be replaced at no cost to consumers.
It says the monitoring systems themselves are not being recalled, just the defective strips.
Patients should contact their health care providers to determine testing options if they don’t have any unaffected test strips to use.
The FDA says it is working with Abbott to avoid any potential shortages of useable products. The company says it will take about eight weeks to produce and distribute enough strips to replace all the defective ones that have been distributed.